Pre-order Enquiry
Request Free Sample
Global and United States Age Related Macular Degeneration Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18790907 | Publishing Date : 23-Jul-2021 | No. of pages : 131
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and United States Age Related Macular Degeneration Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Age Related Macular Degeneration Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Type
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Squalamine
1.2.6 Conercept
1.2.7 Lampalizamab
1.2.8 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Application
1.3.2 50-60 Years Old
1.3.3 60-70 Years Old
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drugs Market Size, Estimates and Forecasts
2.1.1 Global Age Related Macular Degeneration Drugs Revenue 2016-2027
2.1.2 Global Age Related Macular Degeneration Drugs Sales 2016-2027
2.2 Global Age Related Macular Degeneration Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Age Related Macular Degeneration Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Age Related Macular Degeneration Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Age Related Macular Degeneration Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Age Related Macular Degeneration Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Age Related Macular Degeneration Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Age Related Macular Degeneration Drugs Revenue Forecast by Region (2022-2027)
3 Global Age Related Macular Degeneration Drugs Competitor Landscape by Players
3.1 Global Top Age Related Macular Degeneration Drugs Manufacturers by Sales
3.1.1 Global Age Related Macular Degeneration Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Age Related Macular Degeneration Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Age Related Macular Degeneration Drugs Manufacturers by Revenue
3.2.1 Key Age Related Macular Degeneration Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Age Related Macular Degeneration Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Age Related Macular Degeneration Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Age Related Macular Degeneration Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Drugs Revenue in 2020
3.2.6 Global Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Age Related Macular Degeneration Drugs Price by Manufacturers
3.4 Global Age Related Macular Degeneration Drugs Manufacturing Base Distribution, Product Types
3.4.1 Age Related Macular Degeneration Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Age Related Macular Degeneration Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Age Related Macular Degeneration Drugs Market Size by Type (2016-2021)
4.1.1 Global Age Related Macular Degeneration Drugs Sales by Type (2016-2021)
4.1.2 Global Age Related Macular Degeneration Drugs Revenue by Type (2016-2021)
4.1.3 Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Age Related Macular Degeneration Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Age Related Macular Degeneration Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Age Related Macular Degeneration Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Age Related Macular Degeneration Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Age Related Macular Degeneration Drugs Market Size by Application (2016-2021)
5.1.1 Global Age Related Macular Degeneration Drugs Sales by Application (2016-2021)
5.1.2 Global Age Related Macular Degeneration Drugs Revenue by Application (2016-2021)
5.1.3 Age Related Macular Degeneration Drugs Price by Application (2016-2021)
5.2 Age Related Macular Degeneration Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Age Related Macular Degeneration Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Age Related Macular Degeneration Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Age Related Macular Degeneration Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Age Related Macular Degeneration Drugs Sales YoY Growth 2016-2027
6.1.2 United States Age Related Macular Degeneration Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Age Related Macular Degeneration Drugs Market Share in Global Market 2016-2027
6.2 United States Age Related Macular Degeneration Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Age Related Macular Degeneration Drugs Players by Sales (2016-2021)
6.2.2 United States Top Age Related Macular Degeneration Drugs Players by Revenue (2016-2021)
6.3 United States Age Related Macular Degeneration Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Age Related Macular Degeneration Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Age Related Macular Degeneration Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Age Related Macular Degeneration Drugs Price by Type (2016-2021)
6.4 United States Age Related Macular Degeneration Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Age Related Macular Degeneration Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Age Related Macular Degeneration Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Age Related Macular Degeneration Drugs Price Forecast by Type (2022-2027)
6.5 United States Age Related Macular Degeneration Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Age Related Macular Degeneration Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Age Related Macular Degeneration Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Age Related Macular Degeneration Drugs Price by Application (2016-2021)
6.6 United States Age Related Macular Degeneration Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Age Related Macular Degeneration Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Age Related Macular Degeneration Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Age Related Macular Degeneration Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
7.2 North America Age Related Macular Degeneration Drugs Market Facts & Figures by Country
7.2.1 North America Age Related Macular Degeneration Drugs Sales by Country (2016-2021)
7.2.2 North America Age Related Macular Degeneration Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Age Related Macular Degeneration Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
9.2 Europe Age Related Macular Degeneration Drugs Market Facts & Figures by Country
9.2.1 Europe Age Related Macular Degeneration Drugs Sales by Country (2016-2021)
9.2.2 Europe Age Related Macular Degeneration Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Age Related Macular Degeneration Drugs Market Facts & Figures by Country
10.2.1 Latin America Age Related Macular Degeneration Drugs Sales by Country (2016-2021)
10.2.2 Latin America Age Related Macular Degeneration Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Age Related Macular Degeneration Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Age Related Macular Degeneration Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Age Related Macular Degeneration Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Bayer Healthcare
12.2.1 Bayer Healthcare Corporation Information
12.2.2 Bayer Healthcare Description and Business Overview
12.2.3 Bayer Healthcare Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Healthcare Age Related Macular Degeneration Drugs Products Offered
12.2.5 Bayer Healthcare Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Age Related Macular Degeneration Drugs Products Offered
12.3.5 Roche Recent Development
12.4 Neurotech Pharmaceuticals
12.4.1 Neurotech Pharmaceuticals Corporation Information
12.4.2 Neurotech Pharmaceuticals Description and Business Overview
12.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Products Offered
12.4.5 Neurotech Pharmaceuticals Recent Development
12.5 Regeneron Pharmaceuticals
12.5.1 Regeneron Pharmaceuticals Corporation Information
12.5.2 Regeneron Pharmaceuticals Description and Business Overview
12.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Products Offered
12.5.5 Regeneron Pharmaceuticals Recent Development
12.6 Allergan
12.6.1 Allergan Corporation Information
12.6.2 Allergan Description and Business Overview
12.6.3 Allergan Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Allergan Age Related Macular Degeneration Drugs Products Offered
12.6.5 Allergan Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Age Related Macular Degeneration Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Age Related Macular Degeneration Drugs Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Age Related Macular Degeneration Drugs Industry Trends
13.2 Age Related Macular Degeneration Drugs Market Drivers
13.3 Age Related Macular Degeneration Drugs Market Challenges
13.4 Age Related Macular Degeneration Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Age Related Macular Degeneration Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Age Related Macular Degeneration Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Lucentis
Table 3. Major Manufacturers of Eylea
Table 4. Major Manufacturers of Avastin
Table 5. Major Manufacturers of Squalamine
Table 6. Major Manufacturers of Conercept
Table 7. Major Manufacturers of Lampalizamab
Table 8. Major Manufacturers of Others
Table 9. Global Age Related Macular Degeneration Drugs Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 10. Global Age Related Macular Degeneration Drugs Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Age Related Macular Degeneration Drugs Sales by Regions (2016-2021) & (K MT)
Table 12. Global Age Related Macular Degeneration Drugs Sales Market Share by Regions (2016-2021)
Table 13. Global Age Related Macular Degeneration Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Age Related Macular Degeneration Drugs Sales Forecast by Region (2022-2027) & (K MT)
Table 15. Global Age Related Macular Degeneration Drugs Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Age Related Macular Degeneration Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Age Related Macular Degeneration Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Age Related Macular Degeneration Drugs Sales by Manufacturers (2016-2021) (K MT)
Table 19. Global Age Related Macular Degeneration Drugs Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Age Related Macular Degeneration Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 21. Age Related Macular Degeneration Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Age Related Macular Degeneration Drugs Revenue Share by Manufacturers (2016-2021)
Table 23. Global Age Related Macular Degeneration Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Age Related Macular Degeneration Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age Related Macular Degeneration Drugs as of 2020)
Table 25. Key Manufacturers Age Related Macular Degeneration Drugs Price (2016-2021) (USD/MT)
Table 26. Age Related Macular Degeneration Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Age Related Macular Degeneration Drugs Product Type
Table 28. Date of International Manufacturers Enter into Age Related Macular Degeneration Drugs Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Age Related Macular Degeneration Drugs Sales by Type (2016-2021) (K MT)
Table 31. Global Age Related Macular Degeneration Drugs Sales Share by Type (2016-2021)
Table 32. Global Age Related Macular Degeneration Drugs Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Age Related Macular Degeneration Drugs Revenue Share by Type (2016-2021)
Table 34. Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 35. Global Age Related Macular Degeneration Drugs Sales Forecast by Type (2022-2027) & (K MT)
Table 36. Global Age Related Macular Degeneration Drugs Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Age Related Macular Degeneration Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Age Related Macular Degeneration Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Age Related Macular Degeneration Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 40. Global Age Related Macular Degeneration Drugs Sales by Application (2016-2021) (K MT)
Table 41. Global Age Related Macular Degeneration Drugs Sales Share by Application (2016-2021)
Table 42. Global Age Related Macular Degeneration Drugs Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Age Related Macular Degeneration Drugs Revenue Share by Application (2016-2021)
Table 44. Age Related Macular Degeneration Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 45. Global Age Related Macular Degeneration Drugs Sales Forecast by Application (2022-2027) & (K MT)
Table 46. Global Age Related Macular Degeneration Drugs Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Age Related Macular Degeneration Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Age Related Macular Degeneration Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Age Related Macular Degeneration Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 50. United States Age Related Macular Degeneration Drugs Sales (K MT) of Key Companies (2016-2021)
Table 51. United States Age Related Macular Degeneration Drugs Sales Share by Company (2016-2021)
Table 52. United States Age Related Macular Degeneration Drugs Revenue (US$ Million) by Company (2016-2021)
Table 53. United States Age Related Macular Degeneration Drugs Revenue Share by Company (2016-2021)
Table 54. United States Age Related Macular Degeneration Drugs Sales (K MT) by Type (2016-2021)
Table 55. United States Age Related Macular Degeneration Drugs Sales Share by Type (2016-2021)
Table 56. United States Age Related Macular Degeneration Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. United States Age Related Macular Degeneration Drugs Price (USD/MT) by Type (2016-2021)
Table 58. United States Age Related Macular Degeneration Drugs Sales (K MT) by Type (2022-2027)
Table 59. United States Age Related Macular Degeneration Drugs Sales Share by Type (2022-2027)
Table 60. United States Age Related Macular Degeneration Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. United States Age Related Macular Degeneration Drugs Revenue Share by Type (2022-2027)
Table 62. United States Age Related Macular Degeneration Drugs Price (USD/MT) by Type (2022-2027)
Table 63. United States Age Related Macular Degeneration Drugs Sales (K MT) by Application (2016-2021)
Table 64. United States Age Related Macular Degeneration Drugs Sales Share by Application (2016-2021)
Table 65. United States Age Related Macular Degeneration Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. United States Age Related Macular Degeneration Drugs Price (USD/MT) by Application (2016-2021)
Table 67. United States Age Related Macular Degeneration Drugs Sales (K MT) by Application (2022-2027)
Table 68. United States Age Related Macular Degeneration Drugs Sales Share by Application (2022-2027)
Table 69. United States Age Related Macular Degeneration Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. United States Age Related Macular Degeneration Drugs Revenue Share by Application (2022-2027)
Table 71. United States Age Related Macular Degeneration Drugs Price (USD/MT) by Application (2022-2027)
Table 72. North America Age Related Macular Degeneration Drugs Sales by Country (2016-2021) & (K MT)
Table 73. North America Age Related Macular Degeneration Drugs Sales Market Share by Country (2016-2021)
Table 74. North America Age Related Macular Degeneration Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Age Related Macular Degeneration Drugs Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Age Related Macular Degeneration Drugs Sales by Region (2016-2021) & (K MT)
Table 77. Asia Pacific Age Related Macular Degeneration Drugs Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Age Related Macular Degeneration Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Age Related Macular Degeneration Drugs Revenue Market Share by Region (2016-2021)
Table 80. Europe Age Related Macular Degeneration Drugs Sales by Country (2016-2021) & (K MT)
Table 81. Europe Age Related Macular Degeneration Drugs Sales Market Share by Country (2016-2021)
Table 82. Europe Age Related Macular Degeneration Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Age Related Macular Degeneration Drugs Revenue Market Share by Country (2016-2021)
Table 84. Latin America Age Related Macular Degeneration Drugs Sales by Country (2016-2021) & (K MT)
Table 85. Latin America Age Related Macular Degeneration Drugs Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Age Related Macular Degeneration Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Age Related Macular Degeneration Drugs Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Age Related Macular Degeneration Drugs Sales by Country (2016-2021) & (K MT)
Table 89. Middle East and Africa Age Related Macular Degeneration Drugs Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Age Related Macular Degeneration Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Market Share by Country (2016-2021)
Table 92. Novartis Corporation Information
Table 93. Novartis Description and Business Overview
Table 94. Novartis Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Novartis Age Related Macular Degeneration Drugs Product
Table 96. Novartis Recent Development
Table 97. Bayer Healthcare Corporation Information
Table 98. Bayer Healthcare Description and Business Overview
Table 99. Bayer Healthcare Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Bayer Healthcare Product
Table 101. Bayer Healthcare Recent Development
Table 102. Roche Corporation Information
Table 103. Roche Description and Business Overview
Table 104. Roche Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Roche Product
Table 106. Roche Recent Development
Table 107. Neurotech Pharmaceuticals Corporation Information
Table 108. Neurotech Pharmaceuticals Description and Business Overview
Table 109. Neurotech Pharmaceuticals Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. Neurotech Pharmaceuticals Product
Table 111. Neurotech Pharmaceuticals Recent Development
Table 112. Regeneron Pharmaceuticals Corporation Information
Table 113. Regeneron Pharmaceuticals Description and Business Overview
Table 114. Regeneron Pharmaceuticals Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Regeneron Pharmaceuticals Product
Table 116. Regeneron Pharmaceuticals Recent Development
Table 117. Allergan Corporation Information
Table 118. Allergan Description and Business Overview
Table 119. Allergan Age Related Macular Degeneration Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. Allergan Product
Table 121. Allergan Recent Development
Table 122. Age Related Macular Degeneration Drugs Market Trends
Table 123. Age Related Macular Degeneration Drugs Market Drivers
Table 124. Age Related Macular Degeneration Drugs Market Challenges
Table 125. Age Related Macular Degeneration Drugs Market Restraints
Table 126. Age Related Macular Degeneration Drugs Customers List
Table 127. Age Related Macular Degeneration Drugs Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drugs Product Picture
Figure 2. Global Age Related Macular Degeneration Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Lucentis Product Picture
Figure 4. Eylea Product Picture
Figure 5. Avastin Product Picture
Figure 6. Squalamine Product Picture
Figure 7. Conercept Product Picture
Figure 8. Lampalizamab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Age Related Macular Degeneration Drugs Sales Market Share by Application in 2020 & 2027
Figure 11. 50-60 Years Old
Figure 12. 60-70 Years Old
Figure 13. Others
Figure 14. Age Related Macular Degeneration Drugs Report Years Considered
Figure 15. Global Age Related Macular Degeneration Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Age Related Macular Degeneration Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Age Related Macular Degeneration Drugs Sales 2016-2027 (K MT)
Figure 18. Global Age Related Macular Degeneration Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Age Related Macular Degeneration Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Age Related Macular Degeneration Drugs Sales Market Share by Region in 2020
Figure 21. Global Age Related Macular Degeneration Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Age Related Macular Degeneration Drugs Revenue Market Share by Region in 2020
Figure 23. Global Age Related Macular Degeneration Drugs Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration Drugs Revenue in 2020
Figure 25. Age Related Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Age Related Macular Degeneration Drugs Sales Market Share by Type (2016-2021)
Figure 27. Global Age Related Macular Degeneration Drugs Sales Market Share by Type in 2020
Figure 28. Global Age Related Macular Degeneration Drugs Revenue Market Share by Type (2016-2021)
Figure 29. Global Age Related Macular Degeneration Drugs Revenue Market Share by Type in 2020
Figure 30. Global Age Related Macular Degeneration Drugs Sales Market Share by Application (2016-2021)
Figure 31. Global Age Related Macular Degeneration Drugs Sales Market Share by Application in 2020
Figure 32. Global Age Related Macular Degeneration Drugs Revenue Market Share by Application (2016-2021)
Figure 33. Global Age Related Macular Degeneration Drugs Revenue Market Share by Application in 2020
Figure 34. United States Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2027 (K MT)
Figure 35. United States Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. United States Age Related Macular Degeneration Drugs Market Share in Global Market 2016-2027
Figure 37. United States 5 and 10 Largest Age Related Macular Degeneration Drugs Players Market Share by Revenue in Age Related Macular Degeneration Drugs in 2020
Figure 38. United States Age Related Macular Degeneration Drugs Revenue Share by Type (2016-2021)
Figure 39. United States Age Related Macular Degeneration Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 40. United States Age Related Macular Degeneration Drugs Revenue Share by Application (2016-2021)
Figure 41. United States Age Related Macular Degeneration Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 43. North America Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Age Related Macular Degeneration Drugs Sales Market Share by Country in 2020
Figure 45. North America Age Related Macular Degeneration Drugs Revenue Market Share by Country in 2020
Figure 46. U.S. Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 47. U.S. Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 49. Canada Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 51. Europe Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Age Related Macular Degeneration Drugs Sales Market Share by Country in 2020
Figure 53. Europe Age Related Macular Degeneration Drugs Revenue Market Share by Country in 2020
Figure 54. Germany Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 55. Germany Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 57. France Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 59. U.K. Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 61. Italy Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 63. Russia Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 65. Asia Pacific Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Age Related Macular Degeneration Drugs Sales Market Share by Region in 2020
Figure 67. Asia Pacific Age Related Macular Degeneration Drugs Revenue Market Share by Region in 2020
Figure 68. China Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 69. China Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 71. Japan Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 73. South Korea Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 75. India Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 77. Australia Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Taiwan Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 79. Taiwan Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 81. Indonesia Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 83. Thailand Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 85. Malaysia Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Philippines Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 87. Philippines Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Vietnam Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 89. Vietnam Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Latin America Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 91. Latin America Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Latin America Age Related Macular Degeneration Drugs Sales Market Share by Country in 2020
Figure 93. Latin America Age Related Macular Degeneration Drugs Revenue Market Share by Country in 2020
Figure 94. Mexico Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 95. Mexico Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Brazil Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 97. Brazil Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Argentina Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 99. Argentina Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Middle East and Africa Age Related Macular Degeneration Drugs Sales Growth Rate 2016-2021 (K MT)
Figure 101. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 102. Middle East and Africa Age Related Macular Degeneration Drugs Sales Market Share by Country in 2020
Figure 103. Middle East and Africa Age Related Macular Degeneration Drugs Revenue Market Share by Country in 2020
Figure 104. Turkey Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 105. Turkey Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Saudi Arabia Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 107. Saudi Arabia Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. U.A.E Age Related Macular Degeneration Drugs Sales Growth Rate (2016-2021) (K MT)
Figure 109. U.A.E Age Related Macular Degeneration Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 110. Age Related Macular Degeneration Drugs Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Keyplayers in Global and United States Age Related Macular Degeneration Drugs Market Insights, Forecast to 2027
NovartisBayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
